Format

Send to

Choose Destination
Behav Brain Res. 2014 Jan 1;258:179-86. doi: 10.1016/j.bbr.2013.10.005. Epub 2013 Oct 12.

Hypolocomotive behaviour associated with increased microglia in a prenatal immune activation model with relevance to schizophrenia.

Author information

1
Experimental Laboratory of Translational Neuroscience and Otolaryngology, University of Antwerp, Campus Drie Eiken, D.T.420, Universiteitsplein 1, 2610 Wilrijk, Belgium.

Abstract

Over the past decade a neurodevelopmental animal model with high validity for schizophrenia has been developed based on the environmental risk factor known as maternal immune activation (MIA). The immunological basis of this model, together with extensive data from clinical and preclinical context, suggests the involvement of an aberrant neuro-immune system in the pathophysiology of schizophrenia. The goal of this study was to examine microglia activation in adult behaviourally phenotyped MIA offspring. MIA was induced in pregnant rats using viral mimetic Poly I:C at gestational day 15. Adult offspring were behaviourally phenotyped at postnatal days (PND) 56, 90 and 180 through the evaluation of prepulse inhibition (PPI) of the acoustic startle and spontaneous locomotion. Finally, the presence of activated microglia in brain regions associated with schizophrenia was evaluated using post-mortem immunohistochemistry against OX-42 (CD11b) and ED-1 (CD68). Although a deficit in PPI could not be replicated despite the high number of animals tested, we found an overall decrease in basal startle response and spontaneous locomotion in offspring born to Poly I:C- compared to saline-treated dams, accompanied by increased microglial density with characteristics of non-reactive activation in the chronic stage of the model. These findings provide additional evidence for a role played by microglial activation in schizophrenia-related pathology in general and psychomotor slowing in particular, and warrant extensive research on the underlying mechanism in order to establish new drug targets for the treatment of schizophrenia patients with an inflammatory component.

KEYWORDS:

Autism; Locomotion; Maternal immune activation; Neuroinflammation; Poly I:C; Schizophrenia

PMID:
24129217
DOI:
10.1016/j.bbr.2013.10.005
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center